Team:Tsinghua

From 2014.igem.org

(Difference between revisions)
 
(24 intermediate revisions not shown)
Line 3: Line 3:
{{Team:Tsinghua/css/jquery-1.10.1.min.js}}
{{Team:Tsinghua/css/jquery-1.10.1.min.js}}
<html>
<html>
-
<head>
+
<body onload=' location.href="#anchor1" '>
-
<meta charset="utf-8">
+
-
<title>Tsinghua 2014</title>
+
-
</head>
+
-
 
+
-
<body>
+
<div class="container">
<div class="container">
<div id="sheet1">
<div id="sheet1">
 +
<a id='anchor1' href='#'></a>
<div class="contentbox">
<div class="contentbox">
<span>
<span>
Line 17: Line 13:
</div>
</div>
<div id="text1" class="slideLeft">
<div id="text1" class="slideLeft">
-
<h1>Hi, we are <font color="990099">Team Tsinghua</font> at iGEM 2014. We are working on a gene therapy for Type 1 Diabetes Mellitus (T1DM).</h1>  
+
<h1 class="customtext">Hi! We are <font color="990099">Team Tsinghua</font>. We present to you a <font color="990099">gene therapy</font> for Type 1 Diabetes Mellitus (T1DM).</h1>  
</div>
</div>
</span>
</span>
Line 33: Line 29:
</div>
</div>
<div id="text2">
<div id="text2">
-
<h1 style="font-size: 22px;"><font color="990099">T1DM</font> results from the autoimmune destruction of insulin-producing beta cells in the pancreas. We aim to convert somatic cells into insulin-producing cells regulated by blood glucose, and eliminate the need for constant insulin therapy.</h1>  
+
<h1 class="customtext"><font color="990099">T1DM</font> results from autoimmune destruction of pancreatic beta cells. Our approach converts somatic cells into regulated insulin-producing cells, thus eliminating the need for continuous insulin therapy.</h1>  
</div>
</div>
</span>
</span>
Line 49: Line 45:
</div>
</div>
<div id="text3">
<div id="text3">
-
<h1>We use <font color="990099">Adeno-associated viral (AAV)</font> vectors to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more? </h1>  
+
<h1 class="customtext">We use <font color="990099">Adeno-associated virus (AAV)</font> as a transfection vector to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more? </h1>  
</div>
</div>
</span>
</span>
Line 59: Line 55:
</div>
</div>
<div id="sheet4">
<div id="sheet4">
-
<a href="#">Get Started</a>
+
<a href="https://2014.igem.org/Team:Tsinghua/Main_page">Get Started!</a>
</div>
</div>
</div>
</div>
Line 69: Line 65:
var topOfWindow = $(window).scrollTop();
var topOfWindow = $(window).scrollTop();
if (imagePos < topOfWindow+400) {
if (imagePos < topOfWindow+400) {
-
$(this).addClass("expandup");
+
$(this).addClass("expandUp");
}
}
});
});
Line 80: Line 76:
var topOfWindow = $(window).scrollTop();
var topOfWindow = $(window).scrollTop();
-
if (imagePos < topOfWindow+800) {
+
if (imagePos < topOfWindow+400) {
$(this).addClass("expandOpen");
$(this).addClass("expandOpen");
}
}

Latest revision as of 18:20, 15 October 2014

Hi! We are Team Tsinghua. We present to you a gene therapy for Type 1 Diabetes Mellitus (T1DM).

Scroll down

T1DM results from autoimmune destruction of pancreatic beta cells. Our approach converts somatic cells into regulated insulin-producing cells, thus eliminating the need for continuous insulin therapy.

Scroll down

We use Adeno-associated virus (AAV) as a transfection vector to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more?

Scroll down

Retrieved from "http://2014.igem.org/Team:Tsinghua"